{"id":"W2568516571","doi":"10.1016/j.jtho.2016.11.366","title":"OA24.01 Radiotherapy Quality Assurance of Concurrent Chemoradiotherapy in PROCLAIM Phase III Trial","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada); Trillium Health Centre","funders":"","keywords":"Medicine; Chemoradiotherapy; Radiation therapy; Adverse effect; Quality assurance; Hazard ratio; Nuclear medicine; Internal medicine; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002096856,0.0008546701,0.001902325,0.0003211872,0.0004158952,0.001673379,0.0008276736,0.0008182376,0.005138972],"category_scores_gemma":[0.002166681,0.0003112909,0.002035093,0.0005033229,0.0007581818,0.0006398271,0.0004719066,0.002677889,0.0007961713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00131874,"about_ca_system_score_gemma":0.001847704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00129241,"about_ca_topic_score_gemma":0.002715981,"domain_scores_codex":[0.9992774,0.0003726767,0.00003472942,0.000116541,0.0000723641,0.0001262764],"domain_scores_gemma":[0.9989933,0.0001875711,0.0003099685,0.0001233147,0.00007572938,0.0003100126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8131962,0.008702408,0.004887315,0.001271737,0.005292456,0.00005604626,0.0001259471,0.003782012,0.008772656,0.0008091906,0.007830132,0.145274],"study_design_scores_gemma":[0.7442877,0.2230565,0.01744031,0.0001534421,0.00331203,0.0001133031,0.00005634467,0.001916666,0.002047296,0.0006496761,0.006919336,0.00004741106],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816896,0.006792847,0.0008466756,0.001724356,0.0004535854,0.001696999,0.001722328,0.000233236,0.004840469],"genre_scores_gemma":[0.9869713,0.001952487,0.001514646,0.001021752,0.0002500801,0.00199642,0.002145816,0.00006101627,0.004086469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005138972,"threshold_uncertainty_score":0.01719153,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1380196612347414,"score_gpt":0.4903947737091209,"score_spread":0.3523751124743796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}